CORRELATION OF T-CELL LYMPHOMA SUBTYPES WITH ANEMIA AT DR MOHAMMAD HOESIN HOSPITAL PALEMBANG 2018-2022
Main Article Content
Lymphoma is divided into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Among NHL T-cell lymphoma is a rare malignancy of T cells, accounts for 12% of all NHL cases, it is further classified into 53 subtypes by WHO. T-cell lymphoma generally have worse prognosis than those B cells. In 2020 there were 16.125 new cases in Indonesia with 9.024 deaths for all ages and genders. Anemia occurs in some cases of lymphoma, which will make the prognosis of lymphoma worse. This study aims to determine the relationship between T-cell lymphoma subtype and anemia. This observational analytic study utilized a cross-sectional design conducted at the Department of Anatomic Pathology Faculty of Medicine Sriwiaya University/Dr. Mohammad Hoesin Palembang Hospital (RSMH) and the central laboratory of RSMH. The samples from this study were all patients who were diagnosed histopathologically and immunohistochemically as T cell lymphoma at RSMH Palembang from 2018 to 2022. Among 38 samples, T-cell lymphoma predominated in the age group <55 years (73,7%), male gender (73,7%), extranodal location (73,7%), and ENKTCL, nasal subtype (55,3%). Anemia occurred in 60,5% cases and most often it is mild anemia (60,9%). There was no significant correlation between T-cell lymphoma subtype and anemia status (*p = 0.178) and T-cell lymphoma subtype and anemia degree (*p = 0.342). It can be concluded that there is no significant correlation between the T-cell lymphoma subtype and anemia.
2. Hardianti MS, Rizki SHM, Arkananda H, Dhyanti AL, Setiawan SA, Indrawati, et al. Anemia in lymphoma patients in Indonesia: the prevalence and predictive factors. Asian Pac J Cancer Biol. 2021;6(4):235–241.
3. Jamil A, Mukammala SKR. Lymphoma [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 May 24]. Available from : https://www.ncbi.nlm.nih.gov/books/NBK560826/
4. Kim JM, Ko YH, Lee SS, Huh J, Kang CS, Kim CW, et al. WHO classification of malignant lymphomas in Korea: report of the third nationwide study. Korean J Pathol. 2011;45(3):254–260
5. Liang X, Guo L, Hu X, Li S, Wen S. Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma. Medicine (United States). 2021;100(13):1-7.
6. Miyoshi H, Ohshima K. Epidemiology of malignant lymphoma and recent progress in research on adult T-cell leukemia/lymphoma in Japan. Int J Hematol. 2018.107;420–427
7. Moullet I, Salles G, Ketterer N, Dumontet C, Bouafa F, NeidhartBerard EM, et al. Frequency and signifcance of anemia in nonHodgkin’s lymphoma patients. Ann Oncol. 1998;9(10):1109-1115
8. Petković I, Popović A, Džunić M, Pejčić I. Nodal and extranodal peripheral T/NK-cell neoplasms: current aspects. is. Acta Fac. 2020;327:99–120
9. Radkiewicz C, Bruchfeld JB, Weibull CE, Jeppesen ML, Frederiksen H, Lambe M, et al. Sex differences in lymphoma incidence and mortality by subtype: a population-based study. Am J Hematol. 2023;98(1):23–30.
10. Sausen DG, Basith A, Muqeemuddin S. EBV and lymphomagenesis. Cancers. 2023;15(7):2133
11. Sharma J, Mahanta D, Sarma A, Ahmed S, Kakoti L, Kataki A. Pattern of nonhodgkin lymphoma in a tertiary care center in Northeast India using Universitas Sriwijaya morphology and immunohistochemistry, Indian J Med Paediatr Oncol; 2019;40:595–597.
12. Soetandyo N, Rebecca RV, Yunti M, Reksodiputro AH. Limfoma komposit :limfoma hodgkin dan limfoma non hodgkin. JPDI. 2018;5(3):146-149.
13. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016 19;127(20):2375-90
14. Turner MC, Andersen ZJ, Baccarelli A, Diver WR, Gapstur SM, Pope CA, et al. Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations. CA Cancer J Clin. 2020;70(6):460–79.
15. United Nations Children’s Fund. Situasi anak di Indonesia – tren, peluang, dan tantangan dalam memenuhi hak-hak anak. Jakarta: UNICEF Indonesia; 2020.
16. Varghese MT, Alsubait S. T-Cell Lymphoma [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited June 11 2023]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK564354/
17. Winarto D, Made N, Rena RA, Losen Adnyana W, dkk. Kadar hemoglobin awal sebagai faktor prognostik penderita limfoma non-hodgkin (LNH) yang menjalani kemoterapi. JPD Unud. 2018;2(2):38-43.
18. Yasmeen T, Ali J, Khan K, Siddiqui N. Frequency and causes of anemia in lymphoma patients. Pak J Med Sci. 2019;35(1):61–65
